Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloidosis, Immunoglobulin Light-chain”

270 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 270 results

Testing effectiveness (Phase 2)Study completedNCT05968846
What this trial is testing

Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load

Who this might be right for
Systemic Amyloidosis
University of Tennessee Graduate School of Medicine 19
Testing effectiveness (Phase 2)Study completedNCT00091260
What this trial is testing

CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Vaishali Sanchorawala 82
Early research (Phase 1)Ended earlyNCT01807286
What this trial is testing

Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT01677286
What this trial is testing

Safety and Effect of Doxycycline in Patients With Amyloidosis

Who this might be right for
Amyloidosis
Boston University 25
Large-scale testing (Phase 3)Study completedNCT00070382
What this trial is testing

Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT06649695
What this trial is testing

A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
European Myeloma Network B.V. 30
Testing effectiveness (Phase 2)Study completedNCT00547365
What this trial is testing

Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
University of Tennessee 10
Testing effectiveness (Phase 2)Study completedNCT00416624
What this trial is testing

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 239
Post-approval studies (Phase 4)UnknownNCT04612582
What this trial is testing

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Who this might be right for
Immunoglobulin Light-Chain Amyloidosis
Guangdong Provincial People's Hospital 70
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Testing effectiveness (Phase 2)Study completedNCT00679367
What this trial is testing

Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Boston Medical Center 16
Not applicableLooking for participantsNCT00935090
What this trial is testing

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT01777243
What this trial is testing

Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis

Who this might be right for
Amyloidosis
GlaxoSmithKline 25
Not applicableStudy completedNCT06571864
What this trial is testing

AL Amyloidosis and Anti-CD38-Daratunumab

Who this might be right for
Amyloidosis
University of Turin, Italy 14
Not applicableStudy completedNCT02055534
What this trial is testing

Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis

Who this might be right for
Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 144
Testing effectiveness (Phase 2)Study completedNCT01222260
What this trial is testing

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

Who this might be right for
AL Amyloidosis
Columbia University 40
Early research (Phase 1)Ended earlyNCT03000660
What this trial is testing

Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis

Who this might be right for
AL Amyloidosis
Tufts Medical Center 3
Large-scale testing (Phase 3)Looking for participantsNCT05184088
What this trial is testing

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

Who this might be right for
Cardiac AmyloidosisAL AmyloidosisATTR Amyloidosis
Life Molecular Imaging GmbH 200
Testing effectiveness (Phase 2)Looking for participantsNCT06418477
What this trial is testing

Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD

Who this might be right for
Monoclonal Gammopathy of Renal Significance
Peking University People's Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05066607
What this trial is testing

Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy

Who this might be right for
AL Amyloidosis
Intergroupe Francophone du Myelome 46
Load More Results